In a groundbreaking development for the fight against Alzheimer's disease, researchers have unveiled a novel drug that promising results in recent clinical trials. The pharmaceutical, known as Compound X, has demonstrated the capacity to halt the progression of cognitive impairment in patients with Alzheimer's disease. Early findings suggest that t… Read More

Pharma teams can now assess biomarker coverage across datma’s federated network with no cost, contracts, or IT support required. datma, a leader in federated real-world data access, today announced the launch more info of the Federated Biomarker Explorer, a new application that allows pharmaceutical teams to evaluate real-world biomarker coverag… Read More